| Literature DB >> 17562241 |
Ajay Gupta1, Mehar Chand Sharma, Vinod Kochupillai, Ganesan Kichendasse, Anuradha Gupta, Surender Atri, Kunjehari Medhi.
Abstract
A 38-year-old man, a chronic smoker, presented to us with a large left upper lobe mass lesion and left-sided pleural effusion. After resection, a residual mass remained. On histopathologic examination, a diagnosis of pleiomorphic rhabdomyosarcoma stage III of the lung was made. Chemotherapy using IRS (Intergroup Rhabdomyosarcoma Study) IV protocol with radiation therapy (RT) at week 9 was planned. The tumor progressed within 6 weeks of chemotherapy to involve the diaphragm and the pericardium (inoperable disease). Chemotherapy was abandoned, and we referred the patient to receive RT, which the patient refused; and he died of progressive disease 1 month later. The poor response to chemotherapy suggests that alternative treatment modalities including RT/second-look surgery or novel chemotherapeutic strategies should be tried in such a case.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17562241 DOI: 10.3816/CLC.2007.n.021
Source DB: PubMed Journal: Clin Lung Cancer ISSN: 1525-7304 Impact factor: 4.785